Special Session: New Drug Approvals for Metastatic Breast Cancer

Special Session: "Regulatory Insights to the 2021 Early Stage Breast Cancer Approvals..."Подробнее

WEBINAR: New Treatment Options for Metastatic Breast CancerПодробнее

ASCO 2022: Metastatic Breast Cancer Drug Therapy RecapПодробнее

New drug approvals for metastatic breast cancerПодробнее

New Results on Treatment of Metastatic Breast Cancer - European Cancer Congress (ESMO) 2023Подробнее

Updates in Metastatic Breast Cancer: 2023 West OncologyПодробнее

FDA expands approval for drug to treat early-stage breast cancerПодробнее

Medical advances in the treatment of metastatic breast cancerПодробнее

New drug could lower chances of breast cancer returningПодробнее

2021 West Oncology | Breast Cancer | New Advances for Metastatic TNBCПодробнее

Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review ConferenceПодробнее

Metastatic Breast Cancer | 2022 OneOncology ConferenceПодробнее

Exploring Breakthrough Treatments in Metastatic Breast CancerПодробнее

BRACAnalysis CDx approved by FDA for metastatic breast cancerПодробнее

Advancements in metastatic breast cancer treatmentПодробнее

Game-Changing Drug Gives Stage 4 Breast Cancer Patients New Hope | Cancer Straight TalkПодробнее

Dr. Hamilton on the FDA Approval of Tucatinib in HER2+ Breast CancerПодробнее

New Data and New Drugs for Metastatic Breast Cancer - Recommendations by Patient SubtypeПодробнее

New Treatments for Metastatic Breast CancerПодробнее